使用SEER数据库对质瘤患者的风险预测和治疗评估:一项前性观察性研究
XinRong Li1, Yan Shao2, ZeMing Wang3
1Department of Integrative Medicine and Medical Oncology, Shengzhou People's Hospital (the First Affiliated Hospital of Zhejiang University Shengzhou Branch), Shengzhou, Zhejiang, People's Republic of China 57258782@qq.com.
BMJ open
|December 9, 2023
概括
这项研究开发了一个名图,以预测质瘤患者的死亡风险和治疗影响. 研究结果表明,手术,放射治疗和化疗通常会改善预后,而IDH状态会影响疗效.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
背景情况:
- 质瘤的预后是复杂的,受临床因素和治疗的影响.
- 预测模型对于质瘤患者个性化治疗策略至关重要.
研究的目的:
- 开发一种用于预测质瘤患者死亡风险的诺米克图.
- 评估手术,放射治疗和化疗对质瘤预后的影响.
主要方法:
- 使用了监测流行病学和最终结果 (SEER) 数据库 (3798例).
- 在独立的预后因素上使用考克斯回归分析构建了一个名图.
- 将患者分为分层风险组 (高,中,低) 并使用日志等级测试分析治疗效果.
主要成果:
- 确定年龄,种族,阶段,组织学,年级,手术,放射治疗和化疗作为独立的预后因素.
- 命名图表表现出良好的预测性歧视和一致性.
- 手术,放射治疗和化疗通常改善了预后,但在特定的风险群体中例外.
- 异酸脱酶1/2 (IDH1/2) 野生型患者在治疗后的生存率更好,而IDH突变型患者的结果不一致.
结论:
- 手术,放射治疗和化疗改善了质瘤的预后.
- 为高风险和低风险患者量身定制治疗选择需要进一步调查.
- IDH突变状态可以作为预测质瘤治疗反应的可靠生物标志物.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


